Related Experiment Videos

HLA expression and cancer--14th IHIWS immunohistochemistry quality control exercise exchange results

S F Chew1, C Kanaan, B D Tait

  • 1Victorian Transplantation and Immunogenetic Service, Melbourne, Australia.

Tissue Antigens
|April 21, 2007
PubMed

Insights

A quality control exercise for immunohistochemistry (IH) in human leukocyte antigen (HLA) expression found good agreement between laboratories, but identified variability in staining and interpretation. Further exercises are recommended to address these differences.

Area of Science:

  • Immunogenetics
  • Histopathology
  • Quality Control

Background:

  • The 14th International HLA and Immunogenetics Workshop (IHIWS) included a component focused on HLA expression and cancer.
  • Immunohistochemistry (IH) is a crucial technique for evaluating protein expression in tissues, particularly in cancer research.

Purpose of the Study:

  • To assess the quality and consistency of immunohistochemistry (IH) performance and interpretation among participating laboratories.
  • To identify areas of variability in IH staining and result interpretation within the context of HLA expression in melanoma.

Main Methods:

  • Six laboratories performed IH using three specific monoclonal antibodies (HC-10, beta2m, SI00) on serial melanoma tissue sections.
  • High-resolution digital photographs of stained sections were distributed for interpretation to evaluate concordance.

Main Results:

  • Generally good agreement was observed between laboratories in IH staining and interpretation.
  • Several differences in staining intensity and interpretation of IH results were identified.
  • High concordance was achieved in the interpretation of digital photographs, suggesting improved consistency.

Conclusions:

  • While overall agreement was good, specific areas of variability in IH staining and interpretation require further investigation.
  • Continued quality control exercises are essential for standardizing IH techniques and improving the reliability of results in immunogenetics research.
  • Standardization of IH protocols and interpretation guidelines is recommended to minimize inter-laboratory variability.